Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Forage Genetics International is a U.S.-based agricultural biotechnology and seed company focused on alfalfa genetics, forage seed development, and trait commercialization. The company develops and markets value-added alfalfa seed products and technologies, including HarvXtra alfalfa with Roundup Ready Technology, Roundup Ready alfalfa, and the UltraCut alfalfa disease package. Its business centers on plant breeding, trait development, seed production, and agronomic support for forage growers rather than human therapeutics or healthcare. Forage Genetics International operates as a wholly owned subsidiary of Land O'Lakes and positions itself as a leader in value-added alfalfa and forage innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Forage Genetics International.